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Abstract: Breast milk (BM) is considered as a reference for infant nutrition. The role of bioactive
components, such as cytokines, hormones, growth factors (GFs) and fatty acids (FAs) is poorly
known, but they might be implicated in immune response development. The aim of this study
was to identify the lipid profile and the spectrum of cytokines and neuronal GF in BM samples
and analyse the influence of gestational age and lactation time on these components. This study
used a longitudinal prospective method for the characterization of cytokines, FAs and GFs global
profiles in 120 BM samples from 40 healthy mothers (20 preterm and 20 term) collected as colostrum,
transitional and mature milk. The cytokines were analysed by protein array (Ray Bior Human
Cytokine Array G6. Ray Biotech, Inc. Norcross, GA, USA) and the FAs were analysed by gas
chromatography. The FA profile was similar between the term and the preterm BM samples.
Omega-3-α-linoleic and docosahexaenoic acid (DHA) and omega-6-linoleic acid were the most
abundant in the term and preterm samples during lactation. Omega-3 ETA and omega-3 EPA we
observed exclusively in the preterm samples. The cytokine profile showed a different trend based on
gestational age. A significantly higher expression of neurotrophic factors was found in the mature
preterm milk samples as compared to the mature term samples. Our study is the first to identify the
influence and interactions of perinatal factors on cytokine, GFs and FAs in human milk.
Keywords: human milk; breast milk; breastfeeding; fatty acids; cytokines; growth factors;
neurotrophic factor; polyunsaturated fatty acids; docosahexaenoic acid
1. Introduction
Several studies have found that maternal milk is the optimal source of nutrients and an
unmatched supply of essential protective biocomponents for human infants, particularly during
the first months of life. These bioactive components include oligosaccharides, hormones, enzymes,
immunoglobulins (mainly secretory, Immunoglobulin A (IgA), lactoferrin (Lf), growth factors
(GF’s), cytokines, anti-inflammatory agents and microbial factors, which are poorly understood
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and which are probably implicated in immune response development [1–3]. Cytokines are
pluripotent polypeptides that act in autocrine/paracrine modes by binding to specific cellular
receptors [4]. These proteins regulate the inflammatory responses stimulated by an antigenic
challenge and contribute to the development and maturation of the immune system [5]. Numerous
cytokines as interleukin, interferon, macrophage-colony stimulating factor, Tumor Necrosis Factor-α
(TNF-α, granulocyte-colony stimulating factor (G-CSF), etc. have been identified in breast milk
(BM) suggesting that they can be interconnected in the control of the inflammation and infection
response [4,6–10]. Other molecules, such as GFs, can contribute to the development of several
structures, including neuronal components, which are extremely important for the development of
the enteric and central nervous systems [8,11,12].
Regarding nutritional components, human milk is considered to be the source of nutrient
balance for a term infant. Lipids constitute the highest macronutrient components of breast milk
and includes specially long-chain polyunsaturated fatty acids (LC-PUFAs), which not only has a
nutritional function but also metabolic functionality, that are involved in brain development and
are one of the main components of the neuronal membrane. LC-PUFAs consist, among other
things, of docosahexaenoic acid (DHA) (an omega-3 FA), and arachidonic (AA) (an omega-6 FA),
which are influenced by the mother’s diet and other environmental factors [13] and related to
brain development, like in a cohort of pregnant women, it has been demonstrated that maternal
supplementation of very-long-chain omega-3 PUFAs during pregnancy and lactation is favourably
for later mental development in children [14], and other investigation supported the influence of
omega-3 on cognitive development [15–17]. However, foetal accretion of DHA occurs from the last
trimester of gestation that increase the problem into immature infant (usually weighing less than
2500 grams at birth and not physiologically well developed) has substantial difficulty synthesizing
DHA from elongation and desaturation of its FA precursors [13], and that lead the preterm births
(born before the thirty-seventh completed week of gestation) at risk of DHA deficiency [18].
Hypothetically, all of these components could act synergistically in neural development and in
response against inflammation and infection. Several studies have investigated cytokines and growth
factors in human milk, however, scarce data on the relationship between milk compounds including
immunological and FA profiles, are available. Based on the previous information of the development
of human milk from immature to mature, and the relationship between some bioactive and key
nutrients of mother milk with immune system, the aim of this study was to study the impact of
gestational age on the evolution during lactation of the lipid profile (FA Profile), and the spectrum of
cytokines and neuronal growth factors (GFs) and also, on their interactions.
2. Material & Methods
2.1. Subjects and Design
A longitudinal prospective study of the characterization of FA profile, cytokines and GFs in
120 breast milk samples from 40 healthy mothers was conducted. The mothers were recruited after
delivery at the Maternity Ward of the Hospital Clínico Universitario de Valencia (Spain) between
2008 and 2014. The study was approved by the Ethics Committee of the Hospital and the Bioethics
Subcommittee of Consejo Superior de Investigaciones Científicas (CSIC). The study complied with
the Declaration of Helsinki, as reviewed in 2000.
To assess the influence of perinatal factors, the breast milk samples were divided into two groups
depending on gestational age: 20 term gestations (infants born at or after 37 weeks of gestation)
and 20 preterm gestations (infants born before 37 weeks of gestation) (Table 1). Samples were
collected within the first month of exclusive breastfeeding and categorized into three subgroups
based on lactation stage as follows: colostrum (1st–6th day postpartum), transitional (7th–15th day
postpartum) and mature milk (from the 16th day onwards).
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Table 1. Clinical characteristics of mother-infant pair included in the study.
Term Gestations (n = 20) Preterm Gestations (n = 20)
Maternal age (year) 30 (25.0–32.8) 32.1 (27.2–33.7)
Length of pregnancy (week) 39.2 (38.0–40.0) 29 (27–315)
Mode of delivery
Vaginal (%) 10 (50%) 6 (30%)
C-section (%) 10 (50%) 14 (70%)
Birth weight (g) 3200 (3000–3650) 2850 (2500–3000)
Data are shown as median and interquartile range (IQR).
2.2. Breast Milk Samples
Before the sample collection, mothers were given written instructions for the standardized
collection of samples each morning. They washed their hands with soap and their breasts were
cleaned with a swab of 0.5% chlorhexidine solution to reduce the amount of bacteria residing on
the skin. The milk sample collection was carried out with a sterile automatic breast milk pumper
with a vacuum regulator (Medela Symphonyr, Barr, Switzerland), polystyrene suction funnels and
screw-top bottles adapted to suction funnels for direct collection of milk. The bottles and the suction
funnels were autoclaved before use. The milk samples suctioned with the pumper were collected in
bottles (25 mL approximately) and immediately aliquoted in 5 mL tubes, using sterile material, frozen
and stored at ´80 ˝C for later analysis [19].
The fatty layer and cellular elements of the breast milk were removed by two subsequent
centrifugations at 4,000 rpm for 20 min at 4 ˝C, and stored at ´80 ˝C for FAs analysis. The remaining
whey milk was centrifuged at 14,000 rpm for 20 min at 4 ˝C, and the supernatant was used for the
protein array analysis.
2.3. Fatty Acid Analysis
The fatty layer containing the FAs was dissolved in hexane and the fatty esters were methylated
by 2N potassium hydroxide in methanol. The separation and quantification of the different fatty acids
were done with gas liquid chromatography using an Agilent Technologies 7890A device, (Agilent
Technologies, Palo Alto, CA, USA) equipped with a flame ionisation detector (FID) operated with a
split ratio of 20:1. The column was a DB-23 (60 m, 0.25 mm i.d., 0.25 µm coating thickness (Agilent
Technologies). The injector and detector temperatures were held constant at 250 ˝C and 280 ˝C,
respectively. The oven temperature was programmed at 50 ˝C for 1 min and ramped at 25 ˝C/min
to 175 ˝C, followed by further ramping at 4 ˝C/min to 220 ˝C where the temperature was held
constant at 220 ˝C for 18 min. The carrier gas, helium, was held at a constant pressure of 230 kPa.
Chromatographic air and hydrogen (400 mL/min and 35 mL/min, respectively) were supplied to
the FID. The methyl esters were identified by comparing the retention time of the unknowns with
those of the known FA methyl ester (FAME) standards (Supelco 37 component FAME Mix and FAME
marine source, both from Supelco, St. Louis, MO, USA). The relative proportion of each FA in the
flesh was reported as a percentage of the total FAME present in the injected sample. The sum of
the saturated FA (SFA), the monounsaturated FA (MUFA), the polyunsaturated FA (PUFA) and the
highly unsaturated FA, both the n-3 series and the n-6 series and the ratio between n-3 FA and n-6 FA,
were also calculated.
2.4. Protein Array Analysis
Protein concentrations were measured using the Bradford Protein Assay (Bio-Rad) and samples
were normalized at 30 µg of protein for the analysis. The biological samples were then pooled,
including different biological samples in each pool (a total of 12 pools including 10 biological
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samples were analysed). All of the pooled sample measurements were performed in duplicate.
The cytokine profiles were analysed with a semiquantitative human cytokine antibody array that
detects 60 proteins (Table A1) in one experiment (RayBio Human Cytokine Antibody Array G
series VI; Raybiotech Inc., Norcross GA, USA). The array glass slides were washed, incubated
with a biotin-conjugated anti-cytokine mix for 2 h, washed again, and developed for 2 h with
Cy3-conjugated streptavidin. The signals were scanned with a GenePix 4000B scanner (Axon
Instruments, GenePix version 5.0, San Francisco, CA, USA) and analysed with the Raybiotech
analysis tool (Raybiotech Inc., Norcross, GA, USA), a data analysis program based on Microsoft
Excel technology specifically designed for the Raybiotech Antibody Array G Series. Signals were
normalized using the internal, positive and negative controls included in the array. Mean fold-change
values obtained in three independently performed experiments were calculated and used to rank
the expression of cytokines. Any >1.5-fold increase or ď0.65-fold decrease in signal intensity for
a single analyte between samples or groups may be considered to be a measurable and significant
difference in expression, provided that both sets of signals are well above background (Mean
background + 2 standard deviations, accuracy 95%).
2.5. Statistical Analysis and Bioinformatics
Statistical analysis for the validation experiments (means, medians, range, standard deviations,
significance of group differences and linear regression) were evaluated using IBM SPSS software
(release 19.0, SPSS, Inc., Chicago, IL, USA). Between-group comparisons were performed with
Student’s t test. p values < 0.05 were considered significant. Correlation of the parameters was
analysed with Pearson’s correlation analysis. Statistical significance was defined as a two-sided
p-value < 0.05. Principal Component Analysis (PCA) was conducted using SIMCA 14.0 (Umetrics,
Malmö, Sweden).
3. Results
3.1. Fatty Acids Analysis
The relative abundances of FAs present in BM samples (SFAs, MUFAs and PUFAs) were similar
between groups (Figure 1A) almost the same for SFAs and MUFAs (around 40% for colostrum,
transitional and mature as well) and half for PUFAs (around 20%). The ratio of SFAs (Figure 1B)
to unsaturated FAs (MUFAs and PUFAs) showed an increased tendency in human milk term samples
compared to the opposite trend observed in human milk preterm samples during lactation. Levels of
omega FAs showed a different trend in term and preterm human milk samples and along the three
periods of sampling (Figure 2A). So omega-3 FAs increased slightly but during transition period, and
omega-6 FAs decreased in term samples compared to preterm samples, were increase was and with
statistical significance in omega-6 FAs. The ratio of the percentages of omega-6 to omega-3 (Figure 2B)
was higher in preterm than in term samples and it was significant in mature milk.
The relative abundances of specific PUFAs omega 3 and omega-6 showed different trends
between term and preterm during lactation (Figure 3). Omega-3 C18:3 n-3 ALA and C22:6 n-3 DHA
(Figure 3A) and omega 6 C18:2c n-6 Linoleic acids (Figure 3B) were the most abundant in term and
preterm samples during lactation. Remarkable is the finding that C20:3 n-3 ETA (Eicosatrienoic acid)
and C20:5 n-3 EPA (Eicosapentaenoic acid) FAs appeared exclusively in preterm samples.
The FAs Principal Component Analysis (PCA) (Figure 4) showed a differential FA behaviour
in the term and preterm samples, where they follow a parallelism in colostrums and transitional
(difficult to establish with only two points), but in mature human milk samples, they clearly
separate themselves, mainly in preterm mature milk. The principal component 1 (PC1) explained
the differential traits in 37.2% and FA profile evolved a long PC1 from colostrum to mature milk.
In addition, preterm samples were grouped in the lower part.
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Figure 1. Relative abundances  (%) of  fatty acids  (FAs)  (Panel A) and  ratio of  saturated  (SFAs)  to 
unsaturated‐UFAs  (PUFAs  and  MUFAs)  fatty  acids  (Panel  B)  present  in  breast  milk  samples 
according to gestational age and lactation stage. 
 
Figure 2. Relative abundances of unsaturated  fatty acids  (Panel A) and  ratio omega‐6  to omega‐3 
(Panel B) in breast milk samples. The ratio omega‐6 to omega‐3 was significantly different (* p‐value 
< 0.05) between term and preterm samples. 
Figure 1. Relative abundances (%) of fatty acids (FAs) (Panel A) and ratio of saturated (SFAs) to
unsaturated-UFAs (PUFAs and MUFAs) fatty acids (Panel B) present in breast milk samples according
to gestational age and lactation stage.
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Figure 3. Relative abundances  (%) of different PUFAs omega 3  family components  (Panel A) and 
omega‐6  family  components  (Panel  B)  present  in  breast  milk  samples  analysed  by  gas 
chromatography and grouped according to gestational age and lactation stage. 
 
Figure  4. Principal Component Analysis  (PCA)  and Loading Scatter Plot of  the  fatty  acid profile   
(n = 40 fatty acids determined) obtained by gas liquid chromatography. By comparing the score and 
loading plot, the relationships between fatty acids and samples (term and preterm during lactation) 
could be identified. 
3.2. Protein Array Analysis 
Specific cytokine profiles were  found  in each analyzed group  (Table 2). We observed higher 
abundance  of Angiogenin; Epidermal Growth  Factors  (EGF);  Interleukin‐6  (IL‐6); B‐Lymphocyte 
Chemoattractant (BLC); Insulin‐like Growth Factor‐Binding Protein 1 and 2 IGFBP‐1 & IGFBP‐2 and 
Monocyte Chemotactic Protein 1 (MCP‐1) in the term group while EGF; IGFBP‐2; BLC; Angiogenin; 
IL‐6 and Macrophage‐Colony Stimulating Factor  (M‐CSF) were higher  in  the preterm group. The 
PCA analysis showed a differential cytokine profile between term and preterm samples (Figure 5). 
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Monocyte Chemotactic Protein 1 (MCP-1) in the term group while EGF; IGFBP-2; BLC; Angiogenin;
IL-6 and Macrophage-Colony Stimulating Factor (M-CSF) were higher in the preterm group. The
PCA analysis showed a differential cytokine profile between term and preterm samples (Figure 5).
The PC1 explained the differential traits in 84.6% and preterm samples are grouped in same area
while colostrum and transitional term samples are clustered. We could also detect that a higher PC1
was related to lactational stage in preterm. The differential cytokines between term and preterm
samples were BLC; Interferon gamma (IFNγ); Granulocyte Macrophage-Colony Stimulating Factor
(GM-CSF), which were related to preterm samples, and Transforming Growth Factor-β 1 (TGF-β1);
IGFBP-1 and Interleukin-1 (IL1-β) related to term sample. We detected significantly higher expression
of neurotrophic factors in mature preterm milk compared to mature term samples (Table 2), no
differences were found between colostrum and transitional milk. We also found that the other growth
factors and cytokines were significantly higher in preterm than in term samples. In addition, a specific
cytokine and FA profile was found to be related to the groups analyzed (Figure 6). The biplot showed
a direct association with preterm samples and also with term.
Table 2. Fold change table comparing cytokine profile according to lactation stage and gestational age.
A: Fold change table comparing cytokine profile according to lactation stage
Colostrum vs.
Transitional Milk
Colostrum vs.
Mature Milk
Transitional vs.
Mature Milk
Neurtophic factors
Brain-derived neurotrophic
factor (BDNF) 1.00 0.36 * 0.36 *
Ciliary neurotrophic
factor (CNTF) 0.96 0.34 * 0.35 *
Glial cell-derived
neurotrophic factor (GDNF) 0.94 0.14 * 0.15 *
Neurotrophin-3 0.91 0.23 * 0.25 *
Other growth factors
Angiogenin 0.99 0.20 * 0.21 *
Bone morphogenetic
protein 4 0.85 0.07 * 0.08 *
Bone morphogenetic
protein 6 1.07 0.46 * 0.43 *
Epidermal growth factor 0.84 0.13 * 0.16 *
Fibroblast growth factor 6 0.65 * 0.20 * 0.30 *
Fibroblast growth factor 7 0.83 0.38 * 0.46 *
Fms-related tyrosine
kinase-3 ligand 0.88 0.38 * 0.43 *
Insulin-like growth
factor-binding protein 1 1.44 1.05 0.73 *
Insulin-like growth factor-1 1.03 0.37 * 0.35 *
Platelet-derived
growth factor 1.08 0.58 * 0.54 *
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Table 2. Cont.
Cytokines
CK β 8-1 1.13 0.62 * 0.55 *
IFN-gamma 0.90 1.81 * 2.01 *
IL-1β 1.06 0.88 0.83
IL-1α 0.83 0.46 * 0.55 *
IL-2 0.91 0.44 * 0.48 *
IL-3 1.00 0.29 * 0.29 *
IL-4 1.07 0.35 * 0.33 *
IL-5 0.89 0.33 * 0.37 *
IL-6 0.95 0.45 * 0.47 *
IL-7 0.86 0.33 * 0.38 *
IL-10 0.76 0.35 * 0.45 *
IL-13 0.66 0.26 * 0.39 *
IL-15 0.78 0.41 * 0.53 *
Monokine induced by
gamma interferon 0.99 0.60 * 0.61 *
Neutrophil-activating
protein-2 1.01 0.50 * 0.49 *
Thymus and
activation-regulated
chemokine
0.98 0.48 * 0.49 *
Transforming growth
factor-β 3 0.95 0.52 * 0.55 *
Tumor necrosis factor-α 0.95 0.45 * 0.47 *
Tumor necrosis factor-β 0.95 0.20 * 0.21 *
Chemoattractant cytokines
Eotaxin 1.14 0.30 * 0.27 *
Fractalkine 0.84 0.19 * 0.23 *
Granulocyte chemotactic
protein 2 0.95 0.47 * 0.49 *
Granulocyte-macrophage
colony-stimulating factor 0.88 1.41 1.61 *
I-309 0.89 0.56 * 0.63 *
Monocyte chemoattractant
protein-1 1.05 0.72 0.69
Monocyte chemoattractant
protein-2 1.03 0.34 * 0.33 *
Monocyte chemoattractant
protein-3 0.91 0.40 * 0.44 *
Monocyte chemoattractant
protein-4 0.99 0.38 * 0.38 *
Macrophage
colony-stimulating factor 0.95 0.45 * 0.47 *
Human
macrophage-derived
chemokine
1.07 0.39 * 0.37 *
MIP-1-delta 0.82 0.12 * 0.15 *
MIP-3-α 1.26 0.24 * 0.19 *
Pulmonary and
activation-regulated
Cytokine (PARC)
0.83 0.18 * 0.22 *
Stromal cell-derived factor-1 0.97 0.31 * 0.32 *
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Table 2. Cont.
B: Fold change table comparing cytokine profile according to gestational age
Preterm vs. Term
colostrum
Preterm vs. Term
transitional
Preterm vs. Term
mature
Neurtophic factors
Brain-derived neurotrophic
factor (BDNF) 0.89 0.90 2.14 *
Ciliary neurotrophic factor
(CNTF) 0.96 0.96 2.04 *
Glial cell-derived
neurotrophic factor (GDNF) 1.39 1.28 5.06 *
Neurotrophin-3 1.10 0.98 3.60 *
Other growth factors
Angiogenin 0.74 0.89 5.23 *
Bone morphogenetic
protein 4 1.00 0.48 * 12.80 *
Bone morphogenetic
protein 6 1.12 1.12 1.83 *
Epidermal growth factor 0.94 6.61 * 2.78 *
Fibroblast growth factor 6 1.14 1.10 1.54
Fibroblast growth factor 7 1.01 1.85 * 1.40
Fms-related tyrosine
kinase-3 ligand 1.13 1.62 * 1.34
Insulin-like growth
factor-binding protein 1 0.70 1.27 3.80 *
Insulin-like growth factor-1 0.88 0.76 2.43 *
Platelet-derived
growth factor 1.11 0.45 * 2.68 *
Cytokines
CK β 8-1 1.07 0.27 * 3.26 *
IFN-gamma 0.98 2.07 * 0.63 *
IL-1β 1.18 0.40 * 1.70 *
IL-1α 0.95 2.54 * 1.24
IL-2 0.87 1.44 1.59 *
IL-3 1.13 1.46 2.15 *
IL-4 0.90 0.86 2.39 *
IL-5 0.84 1.95 * 1.52 *
IL-6 0.71 0.97 1.97 *
IL-7 0.78 1.40 1.81 *
IL-10 2.87 * 4.08 * 2.09 *
IL-13 1.99 * 3.13 * 2.20 *
IL-15 1.96 * 2.57 * 1.21
Monokine induced by
gamma interferon 0.90 1.07 1.47
Neutrophil-activating
protein-2 0.89 0.59 * 3.89 *
Thymus and
activation-regulated
chemokine
1.03 0.90 1.67 *
Transforming growth
factor-β 3 0.97 1.11 1.62 *
Tumor necrosis factor-α 0.88 0.85 1.79 *
Tumor necrosis factor-β 0.99 1.46 2.84 *
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Table 2. Cont.
Chemoattractant cytokines
Eotaxin 0.97 0.26 * 5.78 *
Fractalkine 1.54 * 1.27 2.71 *
Granulocyte chemotactic
protein 2 1.80 * 0.80 1.97 *
Granulocyte-macrophage
colony-stimulating factor 0.99 2.53 * 0.87
I-309 1.37 0.20 * 2.21 *
Monocyte chemoattractant
protein -1 1.07 0.63 * 5.97 *
Monocyte chemoattractant
protein -2 0.87 0.79 2.02 *
Monocyte chemoattractant
protein -3 0.80 0.78 1.74 *
Monocyte chemoattractant
protein -4 0.97 0.86 2.79 *
Macrophage
colony-stimulating factor 0.56 * 5.41 * 5.61 *
Human
macrophage-derived
chemokine
0.81 1.36 2.81 *
MIP-1-delta 0.66 0.91 1.92 *
MIP-3-α 0.67 0.40 * 6.88 *
Pulmonary and
activation-regulated
Cytokine (PARC)
1.14 3.02 * 3.02 *
Stromal cell-derived factor-1 0.95 1.20 1.56 *
Any >1.5-fold increase orď0.65-fold decrease in signal intensity for a single analyte between samples or groups
may be considered a measurable and significant difference in protein expression (* p value < 0.05); IFN-gamma,
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4. Discussion
Breastfeeding serves as a source of optimal nutrition and bioactive factors for infant
development, especially when maternal nutrition is optimal. Human milk fat content and omega-3
FA (DHA) are crucial for infant neurodevelopment [8,11–17]. Omega-3 FAs have been proven to
contribute to neurophysiological development and disease prevention in infants and children [20].
Omega-3 DHA and omega-6 arachidonic acid (AA) are both concentrated in the infant brain early in
life, reaching approximately 50%–60% of brain dry weight in adults [14,21].
In agreement with previous research, we found higher variability in the FAs profile in term
samples [22]. Compared to the findings of other researches, our data showed higher concentrations
of SFA C12:0 lauric acid and C14:0 myristic acid in colostrum and similar levels of C16:0 palmitic
acid and C18:0 stearic acid during the three stages of lactation in term samples [22]. Regarding
gestational age, similar concentrations of FA were reported in the majority of term and preterm
samples. However, SFA levels were slightly higher in colostrum preterm samples than term samples.
This observation was reflected in the ratio of saturated FAs (SFAs) to unsaturated FAs (PUFAs and
MUFAs): the ratio increased in term samples but decreased in preterm samples (Figure 1B).
Among MUFAs, the C18:1 oleic acid levels in term samples were similar to those found in
previous research [22], while those in preterm samples were lower. In the main result for PUFAs,
C18:2 n-6 linoleic acid levels were more than twice the reported levels for term and preterm samples,
reaching the highest levels in mature milk in term samples [22]. However, our data agree with the
percentages of C18:2 n-6 linoleic acid found during the three lactation stages in term milk samples
drawn from a Spanish population [23]. This observation supports the claim that maternal diet and
geographical location might affect PUFA concentrations.
Regarding omega-3 FA, we detected higher levels in all term samples than preterm samples.
The levels of C18:3 n-3 -linolenic acid in mature milk samples were similar to those previously
reported [22]. In addition, a significant increase in omega-6 levels was shown in the preterm
group during lactation, resulting in a higher omega-6 to omega-3 ratio in the preterm samples than
the observed samples. However, the increase was significant only in mature milk. The omega-6
to omega-3 ratio in term samples was comparable to that in previous data from country-specific
populations [23].
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Our results show similar concentrations of DHA in term samples (0.49%–0.64% during lactation)
and preterm samples (0.38%–0.40%). These levels are higher than in other studies [13] but in the
same range as those reported in our country, Spain [23]. In agreement with previous data [24],
we report high variability in DHA levels in breast milk samples. A recent study conducted
with Hungarian women found lower DHA levels in colostrum than our results, with a significant
decrease during lactation [25]. The likely explanation of these differences is that maternal diet can
change the composition but not the total amount of FA [22,26]. A meta-analysis of 65 studies on
mature human milk involving 2474 women reported an average DHA level of 0.32%˘ 0.22% and
AA level of 0.47% ˘ 0.13% [13]. The DHA levels exhibited great variability by country, with the
highest concentrations found in the Canadian Arctic, Japan, Dominican Republic, Philippines and
Congo. Studies from Spain also found greater DHA concentrations when fish consumption was
high [13]. Omega-3 FA DHA levels have been compared in breast milk samples from a rural area
(Amazonian Bolivia) and the United States [27]. The same study reported omega-6 to omega-3 ratios
of approximately 4:1, while this ratio varied from 10:1 to as high as 20:1 in industrialized diets [27].
High levels of omega-6 have been linked to increased risk of obesity, inflammation and cardiovascular
disease and have been reported to interfere with the synthesis of DHA and other omega-3 fatty
acids [27]. As also shown in our data, other researchers reported no differences in arachidonic acid
and DHA levels in between term and preterm milk samples [28].
We described specific protein profiles in milk samples according to gestational age and
lactation stage (Figure 5 and Table 2). These protein profiles might have different main biological
activities, and some display multiple functional properties, including anti-inflammatory activities
and chemoattractant functions. The majority of cytokines was present in colostrum and decreased
during lactation. However, IFN-γ and M-CSF remained elevated during lactation in term samples.
IFN-gamma is considered a crucial immune modulator in response to intracellular pathogens, and
GM-CSF is an important hematopoietic growth factor, which has received attention in recent research
for its application as an immune adjuvant due to its ability to increase dendritic cell maturation and
function and macrophage activity [29]. We also found cytokines with chemoattracting activity in
colostrum and milk samples, which, as reported, include PARC/CCL18, MIP-3α/CCL20 (mainly for
lymphocytes and immature dendritic cells), MIP-1β/CCL4 (mainly for NK cells and macrophages)
and B lymphocyte chemoattractant/CXCL13 (mainly for naive B lymphocytes) [8]. These activities
which attract various types of cells could benefit the proper development and priming of the intestinal
lymphocytes, which might protect newborns against several diseases immediately after birth and
later in life [30].
In preterm infants, most cytokines increased during lactation and were significantly higher than
in term samples. This trend could be related to the higher protein levels in preterm milk than term
milk during the first month of lactation and could function as a protective factor against infection
and inflammation. Similar patterns have been found: trophic peptides as an epidermal growth factor
(EGF) and a transforming growth factor-α (TGF-α) were elevated in the milk of preterm infants [31].
Levels were significantly higher in extremely preterm (23–27 weeks) samples than older preterm and
full-term samples [31].
In agreement with previous research [8], we found specific growth factors, such as fibroblast
growth factors (FGF-6 and FGF-7), which might contribute to the development of gut structure and
function, including epithelial barrier maturation. Other growth factors, such as platelet-derived
growth factor (PDGF-BB), might mostly influence angiogenesis. Interestingly, we also found
neurotrophic factors, such as brain-derived neurotrophic factor (BDNF), glial cell line-derived
neurotrophic factor (GDNF), and neurotropin-3 (NT-3). BDNF and GDNF induce the growth and
development of the central nervous system and are required for the survival of some primary
sensory neurons during foetal development [32]. Neurotropin-3 acts simultaneously with GDNF
and is considered important to the normal development of the infant enteric nervous system [12].
A recent report confirmed our finding of elevated levels of the transforming growth factor-β
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(TGF-β), which decreased during lactation. Additionally, the recent report found that infants with
necrotizing enterocolitis showed decreased levels of this cytokine, suggesting another benefit of
breastfeeding [33].
In summary, lipid concentration provides a major nutrient in breast milk and includes long-chain
polyunsaturated fatty acids (LCPUFA), which are involved in brain development and are one of
the main components of the neuronal membrane. Researchers have reported higher intellectual
abilities in breastfed infants than formula-fed infants, suggesting that omega-3 FAs have a role in
brain development [11,15–17]. An association among cognition, DHA and the neurotrophic factor
BDNF in human milk has been suggested [11]. Experimental studies have shown the protective
effect of GDNF and CNTF in enteric neuronal survival and suggested that breast milk can promote
neuronal differentiation in rats [34]. The potential interactions between neurotrophic factors and
specific FAs could be relevant to the development of the nervous system. Accordingly, our results
found relationships of the neurotrophic factors CNTF and GDNF with omega-3 EPA and ETA
(p = 0.019 and 0.088, respectively).
5. Conclusions
In conclusion, complex interactions between FA and protein profiles are relevant to infant
development. All of these findings support the crucial interest in human milk for infant development,
especially in infants born preterm. Considering that the preterm infant is frequently fed with
banked human-donor milk, it is important that, as has recently been reported, Holder pasteurization
preserves many growth factors [10]. Further research on milk bioactive-factor interactions is needed
to understand the biological role of breast milk and its impact on infant development and health.
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Appendix
Table A1. The cytokine profiles were analysed with a semiquantitative human cytokine antibody
array that detects 60 proteins..
RayBiorHuman Cytokine Antibody G Series VI
POS 1 POS 2 POS3 NEG NEG Angiogenin BDNF BLC BMP-4 BMP-6
CK β
8-1 CNTF EGF Eotaxin
Eotaxin-2 Eotaxin-3 FGF-6 FGF-7 Fit-3Ligand Fractalkine GCP-2 GDNF GM-CSF I-309
IFN
-gamma IGFBP-1 IGFBP-2 IGFBP-4
IGF-I IL-10 IL-13 IL-15 IL-16 IL-1α IL-1β IL-1ra IL-2 IL-3 IL-4 IL-5 IL-6 IL-7
Leptin LIGHT MCP-1 MCP-2 MCP-3 MCP-4 M-CSF MDC MIG MIP-1delta MIP-3α NAP-2 NT-3 PARC
PDGF-BB RANTES SCF SDF-1 TARC TGF-β1 TGF-β3 TNF-α TNF-β IC1 IC2 IC3 NEG NEG
MCP, monocyte chemotactic protein; IFN-gamma, interferon-γ; IL, interleukin; IGF, insulin-like growth
factor; PDGF-BB, platelet derived growth factor-BB; FGF, fibroblast growth factor; SCF, skp1-cullin-F-box
ligase; SDF, stromal-derived factor; TGF, transforming growth factor; GCP, granulocyte chemotactic protein;
M-CSF, macrophage colony stimulating factor; GDNF, glial cell line–derived neurotrophic factor; TNF,
tumor necrosis factor; MIP, macrophage inflammatory protein; IGFBP, insulin-like growth factor binding
protein; nap, neutrophil-activating peptide; NT, neurotrophin; BDNF, brain-derived neurotrophic factor; BLC,
B-lymphocyte chemoattractant; BMP, bone morphogenetic protein; CNTF, ciliary neurotrophic factor; EGF,
epidermal growth factor.
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